1 Min Read
June 26 (Reuters) - Breckenridge Pharmaceutical Inc
* FDA has granted final approval of its anda azacitidine for injection, 100mg per vial, single-dose vial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.